Data / Form D filings / Arcellx, Inc.
Arcellx, Inc.: Form D filings
Arcellx, Inc., a biotechnology company in Gaithersburg, MD, filed 6 Form D notices with the SEC between 2019 and 2023. The latest, on February 6, 2023, reports $100 million sold of a $100 million offering to 1 investor.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 25 WEST WATKINS MILL ROAD, SUITE A, Gaithersburg, MD, 20878
- Phone
- (240) 327-0603
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1786205
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Feb 6, 2023 | New notice | $100,000,003 | $100,000,003 | 1 | Jan 26, 2023 | sec.gov | |
| Mar 10, 2022 | New notice | $9,999,986 | $9,999,986 | 1 | Feb 27, 2022 | sec.gov | |
| Jul 1, 2021 | Amendment | $120,000,023 | $120,000,023 | 32 | Mar 26, 2021 | sec.gov | |
| Apr 9, 2021 | New notice | $115,000,023 | $115,000,023 | 31 | Mar 26, 2021 | sec.gov | |
| Oct 15, 2019 | Amendment | $83,681,224 | $42,840,613 | $40,840,611 | 18 | Aug 9, 2019 | sec.gov |
| Aug 22, 2019 | New notice | $83,681,224 | $41,840,613 | $41,840,611 | 17 | Aug 9, 2019 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Derek Yoon | Director | |
| Michelle Gilson | Executive Officer | |
| Rami Elghandour | Executive Officer, Director | |
| Ali Behbahani | Director | |
| Olivia Ware | Director | |
| David Lubner | Director | |
| Kavita Patel | Director | |
| Christopher Heery | Executive Officer | |
| Jill Carroll | Director |
Other biotechnology companies in Maryland that filed recently
- Accufy Diagnostics, Inc. $2 million · Oct 28, 2026
- OS Therapies Inc $7.2 million · Oct 23, 2026
- Kaigene, Inc. $55 million · Oct 14, 2026
- Templar Nova, Inc. $7 million · Oct 7, 2026
- Monocacy Therapeutics Inc. $25,000 · Oct 7, 2026
- Seraxis Holdings, Inc. $10 million · Sep 24, 2026
Every Form D from the week of Feb 6, 2023 · All recent filings in Maryland · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what Arcellx, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.